Showing 1 - 20 results of 30 for search 'Yoshitaka Nagai', query time: 0.07s Refine Results
  1. 1
    Protein Aggregation Inhibitors as Disease-Modifying Therapies for Polyglutamine Diseases

    Protein Aggregation Inhibitors as Disease-Modifying Therapies for Polyglutamine Diseases by Eiko N. Minakawa, Yoshitaka Nagai, Yoshitaka Nagai

    Published 2021-02-01
    Get full text
    Article
  2. 2
    Generation of Common Marmoset Model Lines of Spinocerebellar Ataxia Type 3

    Generation of Common Marmoset Model Lines of Spinocerebellar Ataxia Type 3 by Ikuo Tomioka, Ikuo Tomioka, Yoshitaka Nagai, Yoshitaka Nagai, Kazuhiko Seki

    Published 2020-09-01
    Get full text
    Article
  3. 3
    Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases

    Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases by Toshihide Takeuchi, Yoshitaka Nagai

    Published 2017-10-01
    Get full text
    Article
  4. 4
    Lipids as Trans-Acting Effectors for α-Synuclein in the Pathogenesis of Parkinson’s Disease

    Lipids as Trans-Acting Effectors for α-Synuclein in the Pathogenesis of Parkinson’s Disease by Kensuke Ikenaka, Mari Suzuki, Mari Suzuki, Hideki Mochizuki, Yoshitaka Nagai, Yoshitaka Nagai

    Published 2019-07-01
    Get full text
    Article
  5. 5
    Composition of human cerebrospinal fluid cerebroside

    Composition of human cerebrospinal fluid cerebroside by YOSHITAKA NAGAI, JULIAN N. KANFERS

    Published 1971-03-01
    Get full text
    Article
  6. 6
    Developing biomarkers for neurodegenerative diseases using genetically-modified common marmoset models

    Developing biomarkers for neurodegenerative diseases using genetically-modified common marmoset models by Ikuo Tomioka, Yoshitaka Nagai, Kazuhiko Seki

    Published 2018-01-01
    Get full text
    Article
  7. 7
    The effects of safinamide on dysphagia in Parkinson's disease.

    The effects of safinamide on dysphagia in Parkinson's disease. by Makito Hirano, Makoto Samukawa, Chiharu Isono, Yoshitaka Nagai

    Published 2023-01-01
    Get full text
    Article
  8. 8
    The effects of safinamide on dysphagia in Parkinson’s disease

    The effects of safinamide on dysphagia in Parkinson’s disease by Makito Hirano, Makoto Samukawa, Chiharu Isono, Yoshitaka Nagai

    Published 2023-01-01
    Get full text
    Article
  9. 9
    α-Synuclein Transgenic Drosophila As a Model of Parkinson's Disease and Related Synucleinopathies

    α-Synuclein Transgenic Drosophila As a Model of Parkinson's Disease and Related Synucleinopathies by Hideya Mizuno, Nobuhiro Fujikake, Keiji Wada, Yoshitaka Nagai

    Published 2011-01-01
    Get full text
    Article
  10. 10
    The effect of rasagiline on swallowing function in Parkinson's disease

    The effect of rasagiline on swallowing function in Parkinson's disease by Makito Hirano, Makoto Samukawa, Chiharu Isono, Susumu Kusunoki, Yoshitaka Nagai

    Published 2024-01-01
    Get full text
    Article
  11. 11
    Comparison of serum and plasma as a source of blood extracellular vesicles: Increased levels of platelet-derived particles in serum extracellular vesicle fractions alter content profiles from plasma extracellular vesicle fractions.

    Comparison of serum and plasma as a source of blood extracellular vesicles: Increased levels of platelet-derived particles in serum extracellular vesicle fractions alter content pr... by Xiaoman Zhang, Toshihide Takeuchi, Akiko Takeda, Hideki Mochizuki, Yoshitaka Nagai

    Published 2022-01-01
    Get full text
    Article
  12. 12
    Na+/H+ exchangers induce autophagy in neurons and inhibit polyglutamine-induced aggregate formation.

    Na+/H+ exchangers induce autophagy in neurons and inhibit polyglutamine-induced aggregate formation. by Kazuya Togashi, Shuji Wakatsuki, Akiko Furuno, Shinji Tokunaga, Yoshitaka Nagai, Toshiyuki Araki

    Published 2013-01-01
    Get full text
    Article
  13. 13
    <i>C9orf72</i> Hexanucleotide Repeat Expansion-Related Neuropathology Is Attenuated by Nasal Rifampicin in Mice

    <i>C9orf72</i> Hexanucleotide Repeat Expansion-Related Neuropathology Is Attenuated by Nasal Rifampicin in Mice by Yukari Hatanaka, Tomohiro Umeda, Keiko Shigemori, Toshihide Takeuchi, Yoshitaka Nagai, Takami Tomiyama

    Published 2022-05-01
    Get full text
    Article
  14. 14
    Squid nerve sphingomyelin containing an unusual sphingoid base

    Squid nerve sphingomyelin containing an unusual sphingoid base by Yoko Ohashi, Takashi Tanaka, Satoko Akashi, Satoshi Morimoto, Yasuo Kishimoto, Yoshitaka Nagai

    Published 2000-07-01
    Get full text
    Article
  15. 15
    Reconstitution of C9orf72 GGGGCC repeat-associated non-AUG translation with purified human translation factors

    Reconstitution of C9orf72 GGGGCC repeat-associated non-AUG translation with purified human translation factors by Hayato Ito, Kodai Machida, Mayuka Hasumi, Morio Ueyama, Yoshitaka Nagai, Hiroaki Imataka, Hideki Taguchi

    Published 2023-12-01
    Get full text
    Article
  16. 16
    Precise CAG repeat contraction in a Huntington’s Disease mouse model is enabled by gene editing with SpCas9-NG

    Precise CAG repeat contraction in a Huntington’s Disease mouse model is enabled by gene editing with SpCas9-NG by Seiya Oura, Taichi Noda, Naoko Morimura, Seiji Hitoshi, Hiroshi Nishimasu, Yoshitaka Nagai, Osamu Nureki, Masahito Ikawa

    Published 2021-06-01
    Get full text
    Article
  17. 17
    Normalization of Overexpressed α-Synuclein Causing Parkinson's Disease By a Moderate Gene Silencing With RNA Interference

    Normalization of Overexpressed α-Synuclein Causing Parkinson's Disease By a Moderate Gene Silencing With RNA Interference by Masaki Takahashi, Mari Suzuki, Masashi Fukuoka, Nobuhiro Fujikake, Shoko Watanabe, Miho Murata, Keiji Wada, Yoshitaka Nagai, Hirohiko Hohjoh

    Published 2015-01-01
    Get full text
    Article
  18. 18
    Small molecule targeting r(UGGAA) n disrupts RNA foci and alleviates disease phenotype in Drosophila model

    Small molecule targeting r(UGGAA) n disrupts RNA foci and alleviates disease phenotype in Drosophila model by Tomonori Shibata, Konami Nagano, Morio Ueyama, Kensuke Ninomiya, Tetsuro Hirose, Yoshitaka Nagai, Kinya Ishikawa, Gota Kawai, Kazuhiko Nakatani

    Published 2021-01-01
    Get full text
    Article
  19. 19
    Memantine administration prevented chorea movement in Huntington’s disease: a case report

    Memantine administration prevented chorea movement in Huntington’s disease: a case report by Kazumasa Saigoh, Makito Hirano, Yoshiyuki Mitsui, Itsuki Oda, Atsuko Ikegawa, Makoto Samukawa, Keisuke Yoshikawa, Yuko Yamagishi, Susumu Kusunoki, Yoshitaka Nagai

    Published 2023-10-01
    Get full text
    Article
  20. 20
    Knockdown of the Drosophila fused in sarcoma (FUS) homologue causes deficient locomotive behavior and shortening of motoneuron terminal branches.

    Knockdown of the Drosophila fused in sarcoma (FUS) homologue causes deficient locomotive behavior and shortening of motoneuron terminal branches. by Hiroshi Sasayama, Mai Shimamura, Takahiko Tokuda, Yumiko Azuma, Tomokatsu Yoshida, Toshiki Mizuno, Masanori Nakagawa, Nobuhiro Fujikake, Yoshitaka Nagai, Masamitsu Yamaguchi

    Published 2012-01-01
    Get full text
    Article

Search Tools: